These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36931982)

  • 21. Interventions to increase COVID-19 vaccine uptake: a scoping review.
    Andreas M; Iannizzi C; Bohndorf E; Monsef I; Piechotta V; Meerpohl JJ; Skoetz N
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015270. PubMed ID: 35920693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct-to-Consumer Drug Advertisement and Prescribing Practices: Evidence Review and Practical Guidance for Clinicians.
    Franquiz MJ; McGuire AL
    J Gen Intern Med; 2021 May; 36(5):1390-1394. PubMed ID: 32930939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Information versus influence: An analysis of educational, relational, and identity rewards present in direct-to-consumer prescription drug advertising.
    Applequist J; Hintz EA; Quichocho D; Chesser S; Price D; Sturgess S; Giardino M; Young HN
    J Am Pharm Assoc (2003); 2021; 61(6):795-803. PubMed ID: 34238672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicians' Understanding of Clinical Trial Data in Professional Prescription Drug Promotion.
    Moynihan CK; Burke PA; Evans SA; O'Donoghue AC; Sullivan HW
    J Am Board Fam Med; 2018; 31(4):645-649. PubMed ID: 29986991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A scoping review on disparities in exposure to advertising for e-cigarettes and heated tobacco products and implications for advancing a health equity research agenda.
    Grilo G; Crespi E; Cohen JE
    Int J Equity Health; 2021 Oct; 20(1):238. PubMed ID: 34717629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of socialization agents on consumer responses to over-the-counter medicine advertising.
    Lee M; Kang M; King KW; Reid LN
    Res Social Adm Pharm; 2022 Sep; 18(9):3622-3630. PubMed ID: 35165042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asking a doctor versus referring to the Internet: A comparison study on consumers' reactions to DTC (direct-to-consumer) prescription drug advertising.
    Jiang P
    Health Mark Q; 2018; 35(3):209-226. PubMed ID: 30551729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complaints addressed by regulatory authorities in drug advertising targeted at consumers: Cases across three, different countries.
    Song SY; Lee JH; Kim SC; Choi JW; Bae J; Kim E
    Res Social Adm Pharm; 2019 Oct; 15(10):1274-1279. PubMed ID: 30552049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct-to-consumer advertising for pharmaceuticals in Jordan from a gender perspective.
    هديل ع; إبراهيم ا
    East Mediterr Health J; 2016 Sep; 22(6):383-393. PubMed ID: 27686979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attention to price disclosures in direct-to-consumer prescription drug advertising and the impact on drug perceptions.
    Ball JG; Hollin IL
    Res Social Adm Pharm; 2022 Aug; 18(8):3402-3413. PubMed ID: 34819265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The legal and ethical dimensions of direct-to-consumer advertising of prescription drugs: the case of Pfizer and Lipitor in the United States.
    Koku PS
    Health Mark Q; 2021; 38(1):23-34. PubMed ID: 34219606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.
    Frosch DL; Grande D; Tarn DM; Kravitz RL
    Am J Public Health; 2010 Jan; 100(1):24-32. PubMed ID: 19910354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in exposure to televised prescription drug advertising, 2003-2011.
    Kornfield R; Alexander GC; Qato DM; Kim Y; Hirsch JD; Emery SL
    Am J Prev Med; 2015 May; 48(5):575-9. PubMed ID: 25891057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Considering the Future of Pharmaceutical Promotions in Social Media Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Carpentier FR
    Int J Health Policy Manag; 2016 Feb; 5(4):283-5. PubMed ID: 27239874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003-2016.
    Liu J; Avery RJ; Kim JJ; Niederdeppe J
    J Health Commun; 2022 Mar; 27(3):183-191. PubMed ID: 35593131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct-to-consumer advertising of prescription drugs.
    Frosch DL; Grande D
    LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A decade of direct-to-consumer advertising of prescription drugs.
    Donohue JM; Cevasco M; Rosenthal MB
    N Engl J Med; 2007 Aug; 357(7):673-81. PubMed ID: 17699817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Awareness of and attitudes toward direct-to-consumer prescription drug advertising among young adults.
    Alperstein NM
    Health Mark Q; 2014; 31(3):231-45. PubMed ID: 25120044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Attorney Advertising and FDA Action with Prescription Claims: A Time Series Segmented Regression Analysis.
    Tippett EC; Chen BK
    Drug Saf; 2015 Dec; 38(12):1169-78. PubMed ID: 26384489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.